These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38336372)

  • 41. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer.
    Van Trappen P
    Surg Oncol; 2022 May; 41():101745. PubMed ID: 35358912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From Conventional Radiotracer Tc-99(m) with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach.
    Buda A; Papadia A; Zapardiel I; Vizza E; Ghezzi F; De Ponti E; Lissoni AA; Imboden S; Diestro MD; Verri D; Gasparri ML; Bussi B; Di Martino G; de la Noval BD; Mueller M; Crivellaro C
    Ann Surg Oncol; 2016 Sep; 23(9):2959-65. PubMed ID: 27126631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
    Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
    World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
    Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction.
    Buda A; Elisei F; Palazzi S; De Ponti E; Arosio M; Vecchione F; Dell'Anna T; Cuzzocrea M; Bussi B; Giuliani D; Di Martino G; Crivellaro C
    Ann Surg Oncol; 2016 Sep; 23(9):2975-81. PubMed ID: 27116680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer.
    Taşkın S; Sarı ME; Altın D; Ersöz CC; Gökçe A; Yüksel S; Kankaya D; Ortaç F
    Arch Gynecol Obstet; 2019 Jun; 299(6):1667-1672. PubMed ID: 30927059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of indocyanine green as a single tracer for sentinel node biopsy in endometrial cancer.
    Cabezas Palacios MN; García Pineda V; Gracia Segovia M; Diestro Tejeda MD; Hernández Gutiérrez A; Zapardiel Gutiérrez I
    J Obstet Gynaecol Res; 2022 Jan; 48(1):222-229. PubMed ID: 34698419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer.
    Buda A; Bussi B; Di Martino G; Di Lorenzo P; Palazzi S; Grassi T; Milani R
    J Minim Invasive Gynecol; 2016 Feb; 23(2):265-9. PubMed ID: 26455525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases.
    Martinelli F; Ditto A; Signorelli M; Bogani G; Chiappa V; Lorusso D; Scaffa C; Recalcati D; Perotto S; Haeusler E; Raspagliesi F
    Gynecol Oncol; 2017 Sep; 146(3):525-530. PubMed ID: 28625394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.
    Tucker K; Staley SA; Gehrig PA; Soper JT; Boggess JF; Ivanova A; Rossi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):346-351. PubMed ID: 31911534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial Cancer: Analysis of 124 Lymph Nodes.
    Huber D; Hurni Y
    J Minim Invasive Gynecol; 2024 May; 31(5):438-444. PubMed ID: 38428574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
    Buda A; Papadia A; Di Martino G; Imboden S; Bussi B; Guerra L; De Ponti E; Reato C; Gasparri ML; Crivellaro C; Mueller M
    J Minim Invasive Gynecol; 2018; 25(3):455-460. PubMed ID: 29032256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical hysterectomy or trachelectomy.
    Fernandez MA; Clark HD; Iniesta MD; Munsell MF; Frumovitz M; Ramirez PT
    Int J Gynecol Cancer; 2024 Jan; 34(1):28-34. PubMed ID: 38097350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
    Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
    Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer.
    Lee GW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Obstet Gynaecol; 2021 May; 41(4):605-611. PubMed ID: 32815448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
    Rozenholc A; Samouelian V; Warkus T; Gauthier P; Provencher D; Sauthier P; Gauthier F; Drakopoulos P; Cormier B
    Gynecol Oncol; 2019 Jun; 153(3):500-504. PubMed ID: 30902369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.